Program - 63th Days H.P. Klotz - 2020

      

"Heart & Hormones"

Final program (updated 2020/01/14)

THURSDAY June 18th 2020

INTRODUCTION (08:45-09:00) - 

CARDIAC HORMONAL REGULATION: (9h-11h)

  • The heart, an endocrine gland:  natriuretic peptides  Pr Nicolas LAMBLIN, Lille, France
  • Androgen receptors, antihormones and cardiac arrhythmia  Dr Joe Elie SALEM, Ile de France, France
  • Ladies’ heart  Pr Claire MOUNIER-VEHIER, Lille, France
  • Cardiac complications of Turner syndrome  Pr Sophie CHRISTIN-MAITRE, Paris, France

COFFEE BREAK: (11-11h30)

HEART and METABOLISM (11h30-13h)

  • FGF23 and cardiovascular risk  Pr Dominique PRIE, Paris, France
  • Hypoglycemia and heart rhythm disorders in type 1 diabetes  Pr Bogdan NICOLESCU-CATARGI, Bordeaux, France
  • Cardiac complications of lipodystrophic syndromes  Pr Corinne VIGOUROUX, Paris, France

LUNCH (13:00 -14:00)

PARATHYROID GLANDS and HEART (14h-15h30)

  • PTH, a marker of cardiovascular risk  Pr. Damien GRUSON, Bruxelles, Belgium
  • Cardiac consequences of parathyroid disorders  Pr Jens BOLLERSLEV, Olso, Norway

COFFEE BREAK (15h30-16h)

THYROIDE and HEART (16h -18h30)

  • Thyroid hormone and tissue regeneration  Dr Frédéric FLAMANT, Lyon, Paris
  • Is there any reason to treat subclinical hypo and hyperthyroidism Pr Bernadette BIONDI, Naples, Italy
  • Amiodarone-induced hyperthyroidism  Pr Lionel GROUSSIN, Paris, France
  • Cardiac complications of thyroid hormones resistance syndromes  Dr Frédéric ILLOUZ, Angers, France
  • Therapeutic applications of thyroid hormone analogues  Dr Edward VISSER, Rotterdam, Netherlands

FRIDAY June 19th 2020

ALDOSTERONE and HEART (9h-10h30)

  • Cardiac gluco- and mineralocorticoid receptors: from development to pathology  Pr. Karen CHAPMAN, Edinburgh, Scotland
  • Cardiac consequences of primary hyperaldosteronism  Pr Gian Paolo ROSSI, Padova, Italy
  • Antagonists of aldosterone receptors  Pr Michel AZIZI, Paris, France

COFFEE BREAK (10h30-11h)

SEROTONINE and HEART (11h-12h30)

  • Monitoring patients receiving dopamine agonist therapy for hyperprolactinaemia  Pr Craig STILES, Fox Lane, United Kingdom
  • Managing Carcinoid Heart Disease in Patients With Neuroendocrine Tumors  Pr Christos TOUMPANAKIS, London, Royaume-Uni

LUNCH (12h30-13h30)

PHEOCHROMOCYTOMA and HEART (13h30-15h)

  • Receptors and cardiovascular effects of catecholamines  Dr Emmanuelle VIDAL-PETIOT, Paris, France
  • Adrenergic cardiac pathway  Dr Grégoire VANDECASTEELE, Paris, France
  • Mechanisms and diagnosis of stress myocarditis; the heart of pheochromocytomas  Dr Laurence AMAR, Paris, France

HEART and GH (15h-16h)

  • Heart and acromegaly  Pr Peter KAMENICKY, Paris, France
  • The heart of GH deficiency and cardiac effects of treatment  Pr Philippe CHANSON, Paris, France

CONCLUSION (16:00-16:15)


© SFE Janvier 2020

En poursuivant votre navigation, vous acceptez l'utilisation de cookies. En savoir plus

Fermer